不同鸡马立克病疫苗的免疫保护效果比较

doi:10.16431/j.cnki.1671-7236.2024.03.039

摘要/Abstract

摘要： 【目的】对国内外共7个批次/品种(A~D,F~H)的CVI988或CVI988＋HVT商品疫苗进行免疫保护分析,以期了解不同马立克病(MD)疫苗的保护效果,为该病的防控提供参考。【方法】将140只1日龄SPF鸡随机分为9组,G01~G09组,其中G01~G07组(15只/组)分别按推荐剂量免疫A~D及F~H马立克病疫苗,G08(攻毒对照组,15只)和G09(空白对照组,20只)组不免疫,7日龄时G01~G08组分别经腹腔注射马立克病病毒(MDV)超强毒Md5株(1 000 PFU/只),所有鸡隔离饲养120 d。通过检测疫苗毒蚀斑数、疫苗毒复制情况、攻毒后体重差异、临床表现和病理变化综合评估各疫苗的保护力。【结果】7个批次疫苗的病毒蚀斑数均符合国家标准(2 000 PFU/羽份),疫苗F的病毒蚀斑数最高(6 467 PFU/羽份)。以1羽份剂量免疫1日龄SPF鸡后,疫苗F的复制速率相对较快。用Md5株攻毒后,攻毒对照组鸡体重减轻,且有93.3%(14/15)的鸡死亡,100%(15/15)剖检出现MD典型病变;G01~G07各免疫组鸡体重与空白对照组鸡相比,均无显著差异(P＞0.05),死亡比例分别为0/14、3/15、5/15、0/14、0/13、0/15和1/15,剖检出现MD典型病理变化的比例为5/14、8/15、7/15、5/14、3/13、3/15和5/15,攻毒保护试验结果显示,7个批次的马立克病疫苗对鸡均具有一定保护力,保护指数为45.7%~73.3%。【结论】不同厂家生产的鸡马立克病疫苗对MDV超强毒Md5株的攻击具有相似的保护效果,二价苗的保护力(73.3%)高于单价疫苗。

关键词: 马立克病; 商品化疫苗; 攻毒保护试验; 保护指数

Abstract: 【Objective】 To understand the immune protection effects of different commercial Marek’s disease vaccines,and provide valuable data for Marek’s disease prevention and control,this study analyzed the immune protection of 7 batches/varieties (A-D,F-H) of CV1988 or CVI988＋HVT commercial vaccine.【Method】 A total of 140 1-day-old SPF chickens were randomly divided into 9 groups,groups G01 to G07.G01 to G07 (15 chickens/group) were immunized with Marek’s disease vaccine A-D and F-H according to the manufacturer’s recommended dose,respectively,while groups G08 (challenge control group,15 chickens) and G09 (blank control group,20 chickens) were not immunized.At 7 days of age,the chickens of groups G01 to G08 were intraperitoneally injected with Md5 strain (1 000 PFU/bird).All chickens were raised to 120 days of age.The protective effect of each vaccine was evaluated through the examination of virus plaque numbers,vaccine replication,weight differences post-challenge,clinical manifestations,and pathological changes.【Result】 The virus plaque number of all 7 vaccine batches confirmed to national standard (2 000 PFU/feather),and the virus plaque number of vaccine F (6 467 PFU/feather) was the highest.The replication rate of vaccine F was faster than other vaccines.After challenged with Md5 strain,the weight of the challenge control group chickens were decreased,and the unvaccinated chickens challenged with Md5 had 93.3% (14/15) mortality,and 100% (15/15) MD lesions.Compared with blank control group,there was no significant difference in body weight in groups G01 to G07 (P>0.05). The mortality of vaccinated chickens in groups G01-G07 were 0/14,3/15,5/15,0/14,0/13,0/15 and 1/15,respectively.The MD lesion proportion of vaccinated chickens in groups G01-G07 were 5/14,8/15,7/15,5/14,3/13,3/15 and 5/15,respectively.The results of immune challenge protection test showed that 7 batches of Marek’s disease vaccine had a certain protective effect on chickens,and the protection index of these vaccines were 45.7%-73.3%.【Conclusion】 Different manufacturer’s Marek’s disease vaccine demonstrated comparable protective effect against Md5 strain of MDV.Furthermore,the bivalent vaccine exhibited higher protection (73.3%) compared to the monovalent vaccine.

Key words: Marek’s disease; commercial vaccine; challenge protection test; protection index

中图分类号:

S859.79⁺7

杨慧明, 蒲兴, 党海斌, 孙璐, 张国中. 不同鸡马立克病疫苗的免疫保护效果比较[J]. 中国畜牧兽医, 2024, 51(3): 1267-1276.

YANG Huiming, PU Xing, DANG Haibin, SUN Lu, ZHANG Guozhong. Comparative Evaluation of Immunological Protective Efficacy Among Various Marek’s Disease Vaccines in Chickens[J]. China Animal Husbandry and Veterinary Medicine, 2024, 51(3): 1267-1276.

参考文献

[1] SWAYNE D E.禽病学[M].14版.沈阳:辽宁科学技术出版社, 2022. SWAYNE D E.Disease of Poultry[M].14th ed.Shenyang:Liaoning Science and Technology Publishing House, 2022.(in Chinese)
[2] REDDY S M, IZUMIYA Y, LUPIANI B.Marek's disease vaccines:Current status, and strategies for improvement and development of vector vaccines[J].Veterinary Microbiology, 2017, 206:113-120.
[3] 刘涛,马明,梁武,等.鸡马立克氏病火鸡疱疹病毒活疫苗毒价检测方法的建立[J].中国家禽, 2015.37(13):60-62. LIU T, MA M, LIANG W, et al.Establishment of virus-titer detection method for live Turkey herpesvirus vaccine of Marek's disease in chicken[J].China Poultry, 2015, 37(13):60-62.(in Chinese)
[4] TENG M, ZHENG L P, LI H Z, et al.Pathogenicity and pathotype analysis of Henan isolates of Marek's disease virus reveal long-term circulation of highly virulent MDV variant in China[J].Viruses, 2022, 14(8):1651.
[5] 蔡文博,牛成明,高彩霞,等.不同MD免疫抗性鸡羽髓中疫苗毒与超强毒的复制动力学及相关性研究[J].中国预防兽医学报, 2011, 33(3):194-198. CAI W B, NIU C M, GAO C X, et al.Replication dynamics and correlation of vaccine virus and vvMDV in feather follicle epithelium of genetic resistant and susceptible chicken lines to MD[J].Chinese Journal of Preventive Veterinary Medicine, 2011, 33(3):194-198.(in Chinese)
[6] HAQ K, FEAR T, IBRAHEEM A, et al.Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens[J].Avian Pathology, 2012, 41(1):69-75.
[7] GIMENO I M, DUNN J R, CORTES A L, et al.Detection and differentiation of CVI988(Rispens vaccine) from other serotype 1 Marek's disease viruses[J].Avian Disease, 2014, 58(2):232-243.
[8] GIMENO I M, CORTES A L, FAIZ N M, et al.Evaluation of factors influencing efficacy of vaccine strain CVI988 against Marek's disease in meat-type chickens[J].Avian Disease, 2015, 59(3):400-409.
[9] BAIGENT S J, NAIR V K, L E GALLUDEC H.Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus[J].Journal of Virological Methods, 2016, 233:23-36.
[10] 兰兴鸽,张艳萍,于正浩,等.荧光定量PCR方法在鸡马立克氏病疫苗免疫监测中的应用分析[J].中国预防兽医学报, 2021, 43(7):727-733. LAN X G, ZHANG Y P, YU Z H, et al.Application analysis of fluorescence quantitative PCR in monitoring immunization of MD vaccine[J].Chinese Journal of Preventive Veterinary Medicine, 2021, 43(7):727-733.(in Chinese)
[11] BAIGENT S J, SMITH L P, PETHERBRIDGE L J, et al.Differential quantification of cloned CVI988 vaccine strain and virulent RB-1B strain of Marek's disease viruses in chicken tissues, using Real-time PCR[J].Research in Veterinary Science, 2011, 91(1):167-174.
[12] BAIGENT S J, SMITH L P, CURRIE R J, et al.Replication kinetics of Marek's disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation[J].Journal of General Virology, 2005, 86(11):2989-2998.
[13] ISLAM T, RENZ K G, STEPHEN W, et al.Viral kinetics, shedding profile and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-negative chickens[J].Avian Disease, 2013, 57(2):454-463.
[14] 甘军纪,刘秀梵,吴长新.马立克病毒超强毒株(Md5、RB1B)毒力试验[A].中国畜牧兽医学会禽病学分会.中国畜牧兽医学会禽病学分会第十一次学术研讨会论文集[C].2002. GAN J J, LIU X F, WU C X.The virulence test of very virulent Marek's disease virus strain (Md5, RB1B)[A].Poultry Health Branch, Chinese Association of Animal and Veterinary Science.Proceedings of the 11th Symposium of the Chinese Association of Animal and Veterinary Science[C].2002.(in Chinese)
[15] 陈展鸿,罗琼,杨洁,等.广西玉林地区MDV强毒YL2002株的分离鉴定[J].中国兽医科学, 2021, 51(2):193-201. CHEN Z H, LUO Q, YANG J, et al.Isolation and identification of MDV wild strains in Yulin, Guangxi[J].Chinese Veterinary Science, 2021, 51(2):193-201.(in Chinese)
[16] 龚振华,张康,王丽萍,等.超强马立克病病毒株的致病性研究[J].畜牧兽医学报, 2015, 46(7):1191-1200. GONG Z H, ZHANG K, WANG L P, et al.Studies on pathogenicity of a very virulent Marek's disease virus strain[J].Acta Veterinaria et Zootechnica Sinica, 2015, 46(7):1191-1200.(in Chinese)
[17] 李慧姣,李启红,吴涛.血清3型火鸡疱疹病毒疫苗与血清1型CVI988疫苗的效力比较[J].中国兽药杂志, 2002, 36(11):32-34. LI H J, LI Q H, WU T.Comparative efficacy of Turkey herpesvirus (serotype 3) and MD CVI988(serotype 1) vaccine viruses[J].Chinese Journal of Veterinary Drug, 2002, 36(11):32-34.(in Chinese)
[18] 孙玉章,代永联,吴光玉,等.三种鸡马立克氏病疫苗的攻毒保护试验比较研究[J].中国动物检疫, 2015, 32(11):87-90. SUN Y Z, DAI Y L, WU G Y, et al.Comparison of vaccine efficacy in chickens challenges with very virulent MDV strain Md5[J].China Animal Health Inspection, 2015, 32(11):87-90.(in Chinese)
[19] 李向超,赵丽霞,刘浩,等.不同马立克氏病疫苗攻毒保护试验[J].兽医导刊, 2018, 16:209-211. LI X Q, ZHAO L X, LIU H, et al.Challenge protection of different Marek's disease vaccines[J].Veterinary Orientation, 2018, 16:209-211.(in Chinese)
[20] GIMENO I M, CORTES A L, FAIZ N, et al.Efficacy of various HVT vaccines (conventional and recombinant) against Marek's disease in broiler chickens:Effect of dose and age of vaccination[J]. Avian Disease, 2016, 60(3):662-668.
[21] EIDSON C S, PAGE R K, KLEVEN S H.Effectiveness of cell-free or cell-associated Turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus[J].Avian Disease, 1978, 22(4):583-597.
[22] LEMIERE S, WONG S Y, SAINT-GERAND A L, et al.Compatibility of Turkey herpesvirus-infectious bursal disease vector vaccine with Marek's disease Rispens vaccine injected into day-old pullets[J].Avian Disease, 2011, 55(1):113-118.
[23] WITTER R L, NAZERIAN K, PURCHASE H G, et al.Isolation from turkeys of a cell-associated Herpesvirus antigenically related to Marek's disease virus[J]. American Journal of Veterinary Research, 1970, 31(3):525-538.
[24] LI H, GE Z, LUO Q, et al.A highly pathogenic Marek's disease virus isolate from chickens immunized with a bivalent vaccine in China[J].Archives of Virology, 2022, 167(3):861-870.
[25] SUN P, CUI N, LIU L, et al.Attenuation of a recombinant Marek's disease virus lacking the meq oncogene and evaluation on its immune efficacy against Marek's disease virus[J]. Poultry Science, 2020, 99(4):1939-1945.
[26] DENG Q, SHI M, LI Q, et al.Analysis of the evolution and transmission dynamics of the field MDV in China during the years 1995-2020, indicating the emergence of a unique cluster with the molecular characteristics of vv+MDV that has become endemic in Southern China[J].Transboundary and Emerging Diseases, 2021, 68(6):3574-3587.
[27] SHI M Y, LI M, WANG W W, et al.The emergence of a vv+MDV can break through the protections provided by the current vaccines[J].Viruses, 2020, 12(9):1048.
[28] LIU J L, TENG M, ZHENG L P, et al.Emerging hypervirulent Marek's disease virus variants significantly overcome protection conferred by commercial vaccines[J].Viruses, 2023, 15(7):1434.